Half-year report · HY
4972.TEDINET S100WZ18
Period2025-04-01 → 2025-09-30
Filed2025-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥47.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥3.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥3.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.6bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.7bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥2.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥53.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥54.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥55.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥16.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥37.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥38.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥36.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.1bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥999m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥726m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥126.12 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥264.18 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169.28 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 71.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥30m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥30m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | ¥11m |
| Chemicalsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥21.1bn |
| Chemicalsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥21.0bn |
| Chemicalsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥30m |
| Chemicalsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥3.0bn |
| Device Systemreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.7bn |
| Device Systemreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.7bn |
| Device Systemreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥203,000 |
| Device Systemreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥77m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥22.8bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥22.8bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥30m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥37m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥37m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | ¥9m |
| Chemicalsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥23.2bn |
| Chemicalsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥23.2bn |
| Chemicalsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥37m |
| Chemicalsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Device Systemreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| Device Systemreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| Device Systemreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥99,000 |
| Device Systemreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥80m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥24.4bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥24.3bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥37m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 525
| Item | Context | Value | Unit |
|---|---|---|---|
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)綜研化学株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都豊島区高田三丁目29番５号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | InterimInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | InterimInstant | Text · Plus | |
| Notes regarding trade notes receivable discounted or transferred by endorsement (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |